BioMarin Pharmaceutical Inc. (BMRN)

Nasdaq · Healthcare · Biotechnology
$60.41-1.64%As of 2026-11-22 · USD
Last session low $59.84Last session high $62.00
52-week low $49.2652-week high $70.98
Market cap
$11.70B
Sector
Healthcare
P/E (TTM)
150.4x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)59.8In the neutral range (30 to 70)
MACD (12, 26, 9)0.69Above its signal line (0.09); histogram 0.61
Bollinger %B (20, 2)90%Inside the bands (54.10 to 61.09)
SMA 2057.60Price is 4.9% above
SMA 5058.32Price is 3.6% above
SMA 20058.53Price is 3.2% above
ATR (20)3.15% of priceAverage true range per day
52-week position51%In the middle of the 49.26 to 70.98 range

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Insider filings, 90 daysNo purchases and 1 sale (about $1.2M).
Latest fiscal yearEnded 2025-12-31: revenue of $3.22B and an operating margin of 12.7%.

More in Biotechnology